Clinical and laboratory predictors of immune checkpoint inhibitor efficacy in non-small cell lung cancer

被引：0
|
作者：
Christopoulos, P. [1 ]
Kohlhaeufl, J. [1 ]
Bozorgmehr, F. [1 ]
Kuon, J. [1 ]
Schneider, M. [1 ]
Neumann, O. [1 ]
Liersch, S. [1 ]
Heussel, C. [1 ]
Winter, H. [1 ]
Herth, F. [1 ]
Rieken, S. [2 ]
Muley, T. [1 ]
Meister, M. [1 ]
Bischoff, H. [1 ]
Lasitschka, F. [1 ]
Stenzinger, A. [3 ]
Thomas, M. [1 ]
机构：
[1] Thoraxklin Heidelberg, Oncol, Heidelberg, Germany
[2] Univ Hosp Heidelberg, Radiat Oncol, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PATIENT EXPERIENCE OF IMMUNE CHECKPOINT INHIBITOR THERAPY FOR NON-SMALL CELL LUNG CANCER
    Williams, Loretta A.
    Whisenant, Meagan
    Malveaux, Donna
    Singhi, Eric K.
    Altan, Mehmet
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [22] Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer
    Xie, Hao
    Adjei, Alex A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 : S41 - S43
  • [23] The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer
    Watanabe, Hiromi
    Kubo, Toshio
    Ninomiya, Kiichiro
    Kudo, Kenichiro
    Minami, Daisuke
    Murakami, Etsuko
    Ochi, Nobuaki
    Ninomiya, Takashi
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Ohashi, Kadoaki
    Fujiwara, Keiichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (08) : 762 - 765
  • [24] Clinical Responses to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Patient Characteristics and Predictors
    Mittal, Garima
    Salas, Maribel
    Ghazarian, Armen
    Malhotra, Jyoti
    Bates, Benjamin
    Chen, Wenjin
    Setoguchi, Soko
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 168 - 168
  • [25] Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer
    Mark, Nicholas M.
    Kargl, Julia
    Busch, Stephanie E.
    Yang, Grace H. Y.
    Metz, Heather E.
    Zhang, Huajia
    Hubbard, Jesse J.
    Pipavath, Sudhakar N. J.
    Madtes, David K.
    Houghton, A. McGarry
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (03) : 325 - 336
  • [26] Efficacy of immune checkpoint inhibitors in younger patients with non-small cell lung cancer
    Shinkichi Takamori
    Mototsugu Shimokawa
    Takefumi Komiya
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13175 - 13184
  • [27] Efficacy of immune checkpoint inhibitors in younger patients with non-small cell lung cancer
    Takamori, Shinkichi
    Shimokawa, Mototsugu
    Komiya, Takefumi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 13175 - 13184
  • [28] Chronic obstructive pulmonary disease alters immune cell composition and immune checkpoint inhibitor efficacy in non-small cell lung cancer
    Magalhaes Filho, Marcos
    Aguiar, Pedro N., Jr.
    de Mello, Ramon Andrade
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [29] Immune checkpoint pathways in non-small cell lung cancer
    Chae, Young Kwang
    Arya, Ayush
    Iams, Wade
    Cruz, Marcello
    Mohindra, Nisha
    Villaflor, Victoria
    Giles, Francis J.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (05)
  • [30] Immune Checkpoint Modulation for Non-Small Cell Lung Cancer
    Soria, Jean-Charles
    Marabelle, Aurelien
    Brahmer, Julie R.
    Gettinger, Scott
    CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2256 - 2262
12345